CCN5 and systemic sclerosis: Lastly, direct comparison between early ARA and early ATA patients in the CCN5+PTX3+ fibroblast cluster highlights unique autoantibody differences in early-stage SSc, which may start to explain some clinical differences in disease phenotype.